Indiana is an attractive potential location for new and growing biopharma manufacturing companies, boasting low facility operating costs, access to highly-educated candidates, and funding opportunities.

In this article, Mayor Scott Fadness explores the benefits that Fishers, a part of the Indianapolis metropolitan area, has to offer biopharma CDMOs. He also highlights the potential for companies already established in the area, like Genezen, to expand, leading to new jobs and fostering growth in the region’s biotech hub.

Read the full article here: Fishers Innovation in Biopharma Manufacturing